OKT11 cell

SKU:BHC11101115
Bulk Pricing
Overview
Click light‑blue chips for details

OKT11 cell is a Hybridoma (Spleen, B cell) cell line. It is commonly used as an in vitro model for 1 research. Growth characteristics: Suspension, Lymphoblast. Supplied as cryopreserved cells with accompanying batch CoA and quality-control documentation.

Species Mouse
Disease model Leukemia
Morphology Lymphoblast
Growth Properties Suspension
Tissue Hybridoma
Options selector
Catalog no. Size
300500 1 cryovial
Available Options

This cell line is available in the U.S. For non-profit users, please sign and submit the Non-Profit Supply Agreement to orders@biohippo.com before placing an order. For commercial users, please complete the CLEAR Form before ordering, as additional usage fees may apply based on the intended use. For further details, please contact orders@biohippo.com. Products ship after the required agreement is completed; typical delivery is 2–3 business days. Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 10^6 cells for adherent lines or 5 × 10^6 cells for suspension lines (refer to the batch CoA for details).

Field Specification
Mfr No 300500
Species Mouse
The OKT 11 monoclonal antibody is produced by a hybridoma formed through the fusion of spleen cells from immunized mice and mouse myeloma cells (P3X63Ag8U1). Specifically, the spleen cells were taken from mice immunized with leukemic cells from a patient with T-cell acute lymphoblastic leukemia (T-ALL). This hybridoma, designated as OKT 11. The OKT 11 antibody selectively binds to an antigen found on nearly all normal human peripheral T cells and approximately 95% of normal human thymocytes but does not react with B cells or null cells. It plays a crucial role in diagnosing and treating diseases related to T cell abnormalities, such as autoimmune disorders and certain leukemias.

SKU:BHC11101115

Protein expression: immunoglobulin, monoclonal antibody, against human T cell (human T lymphocyte) and human E rosette positive thymocytes (human thymic lymphocyte), against CD2

  • cultureMedium: IMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a)
  • supplements: Supplement the medium with 10% FBS
  • subculturing: Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 1 x 105 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation.
  • freezeMedium: As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Matches this product
10% OFF
10% OFF CELL LINES-Limited-Time Offer
Ends Sep 30 CELL10
15%OFF
15% Off Cancer Antibodies
Ends Sep 30 ONCO15
$50 OFF
$50 Off All ELISA Kits
Limited time ELISA50
FREE SAMPLE
Free Sample – CellTrypase Recombinant Trypsin-Like Enzyme
Limited time offer – availa... FREESAMPLE
FREE SAMPLE
Free Sample – MycoFold™ Growth Factors
Limited time offer – availa... Request Free Sample

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today